title: Characterization and identification of a novel candidate vaccine protein through systematic analysis of extracellular proteins of Erysipelothrix rhusiopathiae.
abstract: Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas, is a facultative intracellular Gram-positive bacterium. It has been shown that animals immunized with a filtrate from E. rhusiopathiae cultures are protected against lethal challenge. In this study, we identified and characterized the extracellular proteins of E. rhusiopathiae to search for novel vaccine antigens. A concentrated culture supernatant from the E. rhusiopathiae Fujisawa strain, which has been found to induce protection in mice, was analyzed using two-dimensional electrophoresis. From more than 40 confirmed protein spots, 16 major protein spots were selected and subjected to N-terminal amino acid sequence determination, and 14 protein spots were successfully identified. The identified proteins included housekeeping proteins and other metabolic enzymes. We searched for surface-localized proteins by analyzing the genomes of two E. rhusiopathiae strains: Fujisawa and ATCC 19414. Genome analysis revealed that the ATCC 19414 strain has three putative surface-exposed choline-binding proteins (CBPs): CbpA, CbpB, and CbpC. Each CBP contains a putative choline-binding domain. The CbpC gene is mutated in Fujisawa, becoming a nonfunctional pseudogene. Immunogold electron microscopy confirmed that CbpA and CbpB, as well as the majority of the metabolic enzymes examined, are associated with the cell surface of E. rhusiopathiae Fujisawa. Immunization with recombinant CbpB, but not with other recombinant CBPs or metabolic enzymes, protected mice against lethal challenge. A phagocytosis assay revealed that antiserum against CbpB promoted opsonin-mediated phagocytosis by murine macrophages in vitro. The protective capabilities of CbpB were confirmed in pigs, suggesting that CbpB could be used as a vaccine antigen.
authors.affiliation: National Institute of Animal Health, Tsukuba, Ibaraki, Japan.
authors.forename: Fang
authors.initials: F
authors.lastname: Shi
authors.forename: Yohsuke
authors.initials: Y
authors.lastname: Ogawa
authors.forename: Akiyuki
authors.initials: A
authors.lastname: Sano
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Harada
authors.forename: Jiro
authors.initials: J
authors.lastname: Hirota
authors.forename: Masahiro
authors.initials: M
authors.lastname: Eguchi
authors.forename: Eiji
authors.initials: E
authors.lastname: Oishi
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Shimoji
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001426:Bacterial Proteins / Q000008:administration & dosage / Q000276:immunology*; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D004888:Erysipelothrix / Q000276:immunology*; D005260:Female; D007114:Immunization; D008264:Macrophages / Q000276:immunology; D008565:Membrane Proteins / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D010587:Phagocytosis / Q000276:immunology; D011994:Recombinant Proteins / Q000276:immunology; D020539:Sequence Analysis, Protein; D013552:Swine; D013554:Swine Erysipelas / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D008565:Membrane Proteins; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic
references.citation: J Bacteriol. 2003 May;185(9):2739-48
references.pmid: 12700253
references.citation: Vet Microbiol. 1992 Jan;30(1):73-85
references.pmid: 1531564
references.citation: BMC Microbiol. 2010 Jul 12;10:190
references.pmid: 20624274
references.citation: Microbiol Mol Biol Rev. 1999 Mar;63(1):174-229
references.pmid: 10066836
references.citation: Trends Microbiol. 2002 May;10(5):205-8
references.pmid: 11973142
references.citation: Infect Immun. 1970 Apr;1(4):380-6
references.pmid: 16557745
references.citation: Mol Microbiol. 1997 Sep;25(5):819-29
references.pmid: 9364908
references.citation: J Bacteriol. 2011 Jun;193(12):2959-71
references.pmid: 21478354
references.citation: Diagn Microbiol Infect Dis. 2011 Feb;69(2):123-9
references.pmid: 21251554
references.citation: Microb Pathog. 1998 Aug;25(2):101-9
references.pmid: 9712689
references.citation: Infect Immun. 1970 Apr;1(4):387-93
references.pmid: 16557746
references.citation: Int J Syst Evol Microbiol. 2013 Jul;63(Pt 7):2727-2741
references.pmid: 23606477
references.citation: Microbiology (Reading). 2006 Feb;152(Pt 2):295-303
references.pmid: 16436417
references.citation: Infect Immun. 2002 Jan;70(1):226-32
references.pmid: 11748187
references.citation: J Bacteriol. 1994 May;176(10):2976-85
references.pmid: 7910604
references.citation: Infect Immun. 2005 Oct;73(10):6237-48
references.pmid: 16177295
references.citation: J Bacteriol. 1989 Dec;171(12):6455-67
references.pmid: 2592342
references.citation: FEMS Microbiol Rev. 2009 May;33(3):572-86
references.pmid: 19396958
references.citation: Vet Microbiol. 2006 Jul 20;115(4):329-38
references.pmid: 16621346
references.citation: J Biol Chem. 1998 Jun 5;273(23):14503-15
references.pmid: 9603964
references.citation: Infect Immun. 1999 Apr;67(4):1646-51
references.pmid: 10084998
references.citation: Infect Immun. 1994 Jul;62(7):2806-10
references.pmid: 8005671
references.citation: Infect Immun. 2012 Nov;80(11):3993-4003
references.pmid: 22949554
references.citation: Clin Vaccine Immunol. 2010 Oct;17(10):1605-11
references.pmid: 20719987
references.citation: Clin Vaccine Immunol. 2012 Sep;19(9):1393-8
references.pmid: 22761300
references.citation: Infect Immun. 1990 Sep;58(9):3116-21
references.pmid: 1696940
references.citation: Vet Microbiol. 1995 Feb;43(2-3):173-82
references.pmid: 7740756
references.citation: J Exp Med. 1992 Aug 1;176(2):415-26
references.pmid: 1500854
references.citation: Infect Immun. 1999 Sep;67(9):4376-82
references.pmid: 10456877
references.citation: Int J Med Microbiol. 2003 Dec;293(6):391-401
references.pmid: 14760970
references.citation: J Vet Diagn Invest. 2008 May;20(3):336-42
references.pmid: 18460622
references.citation: Am J Vet Res. 1987 Feb;48(2):239-42
references.pmid: 3826862
references.citation: Adv Enzymol Relat Areas Mol Biol. 1998;72:279-324
references.pmid: 9559056
references.citation: Microbiol Mol Biol Rev. 2001 Jun;65(2):187-207 ; first page, table of contents
references.pmid: 11381099